Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Acta Oncologica"
DOI: 10.1080/0284186x.2023.2165449
Abstract: Abstract Introduction Treatment with immune checkpoint inhibitors (ICI) has expanded into the adjuvant setting enhancing the importance of knowledge on the immune-related toxicities and their impact on health-related quality of life (HRQoL). Large phase 3… read more here.
Keywords: months ago; status; treatment months; hrqol ... See more keywords
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Sign Up to like & getrecommendations! Published in 2020 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000003869
Abstract: Up to 12 months of elagolix with add-back therapy provided sustained reduction in menstrual blood loss with an acceptable safety profile in women with uterine leiomyomas. read more here.
Keywords: women heavy; uterine leiomyomas; elagolix treatment; heavy menstrual ... See more keywords
[Clinical efficacy observation of omalizumab on patients with moderate to severe allergic asthma for one year].
Sign Up to like & getrecommendations! Published in 2023 at "Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"
DOI: 10.3760/cma.j.cn112150-20221016-00998
Abstract: To observe the symptom control, pulmonary function changes and safety of use of omalizumab in patients with moderate to severe allergic asthma for 1 year. A small sample self-controlled study before and after treatment was… read more here.
Keywords: omalizumab patients; treatment months; moderate severe; months treatment ... See more keywords